Bioprocess Insider

More Topics
Lineage granted stem cell production patent for cancer vax
Regulations
Lineage granted stem cell production patent for cancer vaxLineage granted stem cell production patent for cancer vax

The patent validates a system for production of antigen presenting dendritic cells used in Lineage Cell Therapeutics’ cancer immunotherapy program VAC2

byBPI Staff
Sep 2, 2019
|
1 Min Read
Not all about that base: Catalent organic downside offset by M&A
Deal-Making
Not all about that base: Catalent organic downside offset by M&ANot all about that base: Catalent organic downside offset by M&A
byDan Stanton
Sep 2, 2019
1 Min Read
Why freezing should be a hot topic for cell therapy sector
Upstream & Downstream Processing
Why freezing should be a hot topic for cell therapy sectorWhy freezing should be a hot topic for cell therapy sector
byGareth Macdonald
Aug 29, 2019
1 Min Read
Moderna talks vaccines, from mRNA to Zika
Therapeutic Class
Moderna talks vaccines, from mRNA to ZikaModerna talks vaccines, from mRNA to Zika
byDan Stanton
Aug 28, 2019
1 Min Read
IBBR to lease biomanufacturing plant in ‘high-demand’ Maryland
Facilities & Capacity
IBBR to lease biomanufacturing plant in ‘high-demand’ MarylandIBBR to lease biomanufacturing plant in ‘high-demand’ Maryland
byDan Stanton
Aug 27, 2019
1 Min Read
Streamlining the Antibody Discovery Workflow at ModiQuest Research
Sponsored Content
Streamlining the Antibody Discovery Workflow at ModiQuest ResearchStreamlining the Antibody Discovery Workflow at ModiQuest Research
byBPI Contributor
Aug 26, 2019
1 Min Read
Bavarian Nordic looks to go big on back of smallpox vaccine
Global Markets
Bavarian Nordic looks to go big on back of smallpox vaccine
Bavarian Nordic looks to go big on back of smallpox vaccine
Aug 26, 2019
|
1 Min Read
byDan Stanton
Think your CMO is high maintenance? Let’s hope so
Regulations
Think your CMO is high maintenance? Let’s hope so
Think your CMO is high maintenance? Let’s hope so
Aug 26, 2019
|
1 Min Read
byDan Stanton
EU thumbs up for Biocon biosimilar insulin plant
Regulations
EU thumbs up for Biocon biosimilar insulin plant
EU thumbs up for Biocon biosimilar insulin plant
Aug 23, 2019
|
1 Min Read
byBPI Staff
Halix completes Dutch viral and protein product plant
Facilities & Capacity
Halix completes Dutch viral and protein product plant
Halix completes Dutch viral and protein product plant
Aug 23, 2019
|
1 Min Read
byBPI Staff
US Gov provides Merck extra $23m for Ebola vaccine
Global Markets
US Gov provides Merck extra $23m for Ebola vaccine
US Gov provides Merck extra $23m for Ebola vaccine
Aug 23, 2019
|
1 Min Read
byDan Stanton
Pfizer pumps $500m into NC gene therapy site
Therapeutic Class
Pfizer pumps $500m into NC gene therapy site
Pfizer pumps $500m into NC gene therapy site
Aug 22, 2019
|
1 Min Read
byDan Stanton
Commercial N-1 perfusion carried out by Samsung BioLogics
Upstream & Downstream Processing
Commercial N-1 perfusion carried out by Samsung BioLogics
Commercial N-1 perfusion carried out by Samsung BioLogics
Aug 20, 2019
|
1 Min Read
byBPI Staff
Evotec eyes US commercial biomanufacturing pod
Facilities & Capacity
Evotec eyes US commercial biomanufacturing pod
Evotec eyes US commercial biomanufacturing pod
Aug 20, 2019
|
1 Min Read
byDan Stanton
New Zealand? Firm eyes US ops to prep for commercial peptides
Global Markets
New Zealand? Firm eyes US ops to prep for commercial peptides
New Zealand? Firm eyes US ops to prep for commercial peptides
Aug 20, 2019
|
1 Min Read
byDan Stanton
From zero to $250m: Agilent aims to dominate cell analysis space
Upstream & Downstream Processing
From zero to $250m: Agilent aims to dominate cell analysis space
From zero to $250m: Agilent aims to dominate cell analysis space
Aug 16, 2019
|
1 Min Read
byDan Stanton
Dyadic: Deals stack up as industry looks to ‘game-changing’ expression system
Deal-Making
Dyadic: Deals stack up as industry looks to ‘game-changing’ expression system
Dyadic: Deals stack up as industry looks to ‘game-changing’ expression system
Aug 16, 2019
|
1 Min Read
byDan Stanton
Orchard to open CA plant in 2021 to support gene therapy pipeline
Facilities & Capacity
Orchard to open CA plant in 2021 to support gene therapy pipeline
Orchard to open CA plant in 2021 to support gene therapy pipeline
Aug 16, 2019
|
1 Min Read
byDan Stanton
Sartorius (cell) banks on mammalian manufacturing
Upstream & Downstream Processing
Sartorius (cell) banks on mammalian manufacturing
Sartorius (cell) banks on mammalian manufacturing
Aug 16, 2019
|
1 Min Read
byDan Stanton
CMOs to continue picking up Big Pharma non-core facilities
Facilities & Capacity
CMOs to continue picking up Big Pharma non-core facilities
CMOs to continue picking up Big Pharma non-core facilities
Aug 14, 2019
|
1 Min Read
byDan Stanton
AskBio buys Synpromics, plans expansion
Deal-Making
AskBio buys Synpromics, plans expansion
AskBio buys Synpromics, plans expansion
Aug 13, 2019
|
1 Min Read
byBPI Staff
Lonza to simplify vein-to-vein supply chain with Vineti partnership
Therapeutic Class
Lonza to simplify vein-to-vein supply chain with Vineti partnership
Lonza to simplify vein-to-vein supply chain with Vineti partnership
Aug 13, 2019
|
1 Min Read
byDan Stanton
Momenta drops Humira biosimilar, pays GSK $43m in manufacturing hit
Global Markets
Momenta drops Humira biosimilar, pays GSK $43m in manufacturing hit
Momenta drops Humira biosimilar, pays GSK $43m in manufacturing hit
Aug 12, 2019
|
1 Min Read
byDan Stanton
Bio-Techne: $50m reagent plant will support cell & gene therapies
Facilities & Capacity
Bio-Techne: $50m reagent plant will support cell & gene therapies
Bio-Techne: $50m reagent plant will support cell & gene therapies
Aug 12, 2019
|
1 Min Read
byDan Stanton
FDA and NIIMBL partner to advanced biomanufacturing innovation
Regulations
FDA and NIIMBL partner to advanced biomanufacturing innovation
FDA and NIIMBL partner to advanced biomanufacturing innovation
Aug 9, 2019
|
1 Min Read
byDan Stanton
Pfizer licenses AAV platform for ataxia gene therapy
Deal-Making
Pfizer licenses AAV platform for ataxia gene therapy
Pfizer licenses AAV platform for ataxia gene therapy
Aug 9, 2019
|
1 Min Read
byBPI Staff
Pro-biosimilar policies will not ignite US market, Amgen
Regulations
Pro-biosimilar policies will not ignite US market, Amgen
Pro-biosimilar policies will not ignite US market, Amgen
Aug 9, 2019
|
1 Min Read
byDan Stanton
GE and Millipore drive ‘exceptional’ quarter for Repligen’s Protein A
Upstream & Downstream Processing
GE and Millipore drive ‘exceptional’ quarter for Repligen’s Protein A
GE and Millipore drive ‘exceptional’ quarter for Repligen’s Protein A
Aug 9, 2019
|
1 Min Read
byDan Stanton
FDA and Novartis back Zolgensma amid data manipulation issues
Regulations
FDA and Novartis back Zolgensma amid data manipulation issues
FDA and Novartis back Zolgensma amid data manipulation issues
Aug 7, 2019
|
1 Min Read
byDan Stanton
Samsung BioLogics to make third UCB drug substance
Facilities & Capacity
Samsung BioLogics to make third UCB drug substance
Samsung BioLogics to make third UCB drug substance
Aug 6, 2019
|
1 Min Read
byBPI Staff
COGS crisis: Cell therapy sector must rethink CMC says expert
Therapeutic Class
COGS crisis: Cell therapy sector must rethink CMC says expert
COGS crisis: Cell therapy sector must rethink CMC says expert
Aug 6, 2019
|
1 Min Read
byGareth Macdonald
Novo Nordisk to convert Purdue NC plant to make oral diabetes drug
Facilities & Capacity
Novo Nordisk to convert Purdue NC plant to make oral diabetes drug
Novo Nordisk to convert Purdue NC plant to make oral diabetes drug
Aug 5, 2019
|
1 Min Read
byDan Stanton
Biocon biosimilar captures 21% of US Neulasta market, eyes capacity boost
Global Markets
Biocon biosimilar captures 21% of US Neulasta market, eyes capacity boost
Biocon biosimilar captures 21% of US Neulasta market, eyes capacity boost
Aug 5, 2019
|
1 Min Read
byDan Stanton
A booster shot for vaccines: Univercells working to cut production costs
Global Markets
A booster shot for vaccines: Univercells working to cut production costs
A booster shot for vaccines: Univercells working to cut production costs
Aug 2, 2019
|
1 Min Read
byGareth Macdonald
GE: Learning from MAb automation to tackle CAR-T
Upstream & Downstream Processing
GE: Learning from MAb automation to tackle CAR-T
GE: Learning from MAb automation to tackle CAR-T
Aug 2, 2019
|
1 Min Read
byDan Stanton

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Ask the Expert webcasts
ATE Webcasts
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Ask the Expert webcasts
ATE Webcasts
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Insider News
See all
Dec 2 - Dec 5, 2024
The European Cell and Gene Therapy Congress for Groundbreaking Manufacturing, Commercialisation & Analytical Strategies: World renowned leaders share the latest process development, analytical and market access strategies to improve manufacturing scalability, quality and cost to propel your CGT programmes to commercial success
Learn More

Innovative Technology

Emerson white paper
Sponsored Content
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency

Nov 12, 2024

WuXi Bio white paper
Sponsored Content
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products

Nov 8, 2024

Bora white paper
Sponsored Content
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages

Nov 8, 2024